Free T4 Explained: Normal Ranges, What Affects Results, and When to Retest
Free T4 is the active thyroid hormone your labs actually measure — here is what the range means, why results shift, and how to track trends over time.

Medical disclaimer: The information in this article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Lab results and reference ranges vary by individual, lab, age, sex, and health history. Always consult a qualified healthcare provider before making any decisions about your health, medications, supplements, or lab testing. LabHealthCharts is a data visualization tool — it organizes and displays your lab data, it does not interpret your results or provide medical guidance.
Why Free T4 Is the Thyroid Number That Actually Matters
About 20 million Americans live with some form of thyroid disease, and the majority do not know it. When thyroid function is questioned, most providers start with TSH — but Free T4 is the hormone that tells you what is actually circulating and available to your tissues. If you have ever received a thyroid panel and stared at an abbreviation that seemed interchangeable with everything else on the page, this article is for you.
Free T4 (free thyroxine) is one of the most commonly ordered thyroid markers in clinical medicine. It is not the same as total T4, it is not the same as Free T3, and understanding those distinctions changes how you read your results and the questions you bring to your next appointment.
What Free T4 Actually Measures
The thyroid gland produces two main hormones: thyroxine (T4) and triiodothyronine (T3). T4 is produced in larger quantities and acts primarily as a precursor — it circulates in the blood and is converted to the more metabolically active T3 in target tissues throughout the body.
Most of the T4 in your blood is bound to carrier proteins, particularly thyroxine-binding globulin (TBG). Bound T4 is inactive — it cannot enter cells or drive metabolism. Free T4 refers to the unbound fraction: the hormone not attached to protein, available to actually do something. That is why Free T4 is a more direct measure of thyroid hormone availability than total T4, which combines both bound and unbound forms. This distinction is well-established in endocrinology guidelines from organizations such as the American Thyroid Association.
Free T4 Normal Range: What the Numbers Mean
Reference ranges for Free T4 vary by assay method and laboratory. In conventional US labs reporting in ng/dL, the typical reference range is approximately 0.8 to 1.8 ng/dL. For labs reporting in pmol/L (common in Canada, the UK, and international contexts), the equivalent range is roughly 10 to 23 pmol/L. Some labs use a narrower reference interval depending on the immunoassay platform they use.
A result below the lower bound suggests reduced thyroid hormone production — consistent with hypothyroidism. A result above the upper bound suggests excess thyroid hormone — consistent with hyperthyroidism or, in some cases, overtreatment with thyroid medication. Neither conclusion is automatic from a single number: clinical context, TSH, and symptoms all factor in. A 2023 review in Frontiers in Endocrinology notes that reference interval harmonization across assays remains an ongoing clinical challenge — a meaningful reason why your result from one lab may not be directly comparable to a result from a different lab six months later.
Pregnancy Changes the Range Significantly
Free T4 reference ranges shift during pregnancy, particularly in the first trimester when hCG stimulates thyroid output. Standard non-pregnant reference ranges do not apply. Trimester-specific ranges should be used, and many labs provide these on the report when the ordering provider specifies pregnancy status. The American Thyroid Association's 2017 guidelines on thyroid disease in pregnancy detail these trimester-specific thresholds and are the clinical standard of reference.
Free T4 vs. TSH: Reading Them Together
TSH (thyroid-stimulating hormone) is produced by the pituitary gland and tells the thyroid to make more T4. It operates on a feedback loop: when Free T4 is low, TSH rises to stimulate more production; when Free T4 is high, TSH falls to apply the brakes. This is why TSH is usually the first-line screening test — it is exquisitely sensitive to small changes in thyroid hormone levels.
But TSH alone has limits. The combination of TSH and Free T4 tells a more complete story:
High TSH + Low Free T4: Primary hypothyroidism. The thyroid is underproducing despite pituitary signaling. This is the pattern seen in Hashimoto's thyroiditis, the most common cause of hypothyroidism in the US.
Low TSH + High Free T4: Primary hyperthyroidism. Excess thyroid hormone is suppressing pituitary signaling. Graves' disease is the most common cause.
Low TSH + Low Free T4: Secondary hypothyroidism. The problem is at the pituitary or hypothalamus level, not the thyroid itself. This pattern is less common but clinically important because standard screening would miss it.
Normal TSH + Low-Normal Free T4: A grey zone. Some patients with symptoms of hypothyroidism fall here, and the management is debated. This is where Free T3 and clinical context become relevant.
Free T4 vs. Free T3: The Conversion Question
T4 must be converted to T3 to become metabolically active in most tissues. The enzyme responsible — deiodinase — is affected by nutrient status, chronic illness, caloric restriction, and chronic inflammation. Some people convert T4 to T3 efficiently; others do not, even with normal Free T4 levels. This is the basis for the ongoing clinical debate about whether Free T4 alone tells the full thyroid story.
Mainstream endocrinology guidelines from the European Thyroid Association generally do not recommend routine Free T3 testing in initial screening. However, some clinicians and functional medicine practitioners argue that the Free T3 to Free T4 ratio provides useful information about conversion efficiency, particularly in patients with persistent symptoms on standard levothyroxine therapy. The data supporting combination T4 and T3 treatment remains mixed — a 2019 meta-analysis in JAMA Internal Medicine found some patient subgroups prefer combined therapy but saw no clear benefit on objective measures.
This is genuinely contested territory. The mainstream view is that TSH and Free T4 are sufficient for most patients. A minority of clinicians measure Free T3 routinely and interpret the T3:T4 ratio as a conversion marker. Neither position is fringe, and both have supporting literature. What you ask for should reflect your symptoms, your provider's clinical judgment, and your history.
What Can Push Free T4 Out of Range
Medications
Several commonly used medications can alter Free T4 levels or affect how the assay reads. Biotin (vitamin B7) at high doses — often taken for hair and nail health — is a well-documented source of assay interference. It can cause falsely elevated Free T4 and falsely suppressed TSH on immunoassay-based tests. The FDA issued a safety communication on biotin interference and recommends stopping biotin supplementation at least 2 days before thyroid labs. Other medications that can affect results include amiodarone, lithium, glucocorticoids, and estrogen-containing contraceptives (the latter primarily affects TBG, which impacts total T4 more than Free T4 but can still shift results depending on the assay).
Timing of Thyroid Medication Doses
For anyone taking levothyroxine (synthetic T4), the timing of the blood draw relative to the last dose matters. Taking levothyroxine and then drawing blood within 4 to 6 hours can artificially elevate Free T4 by 15 to 20%. The standard clinical recommendation is to draw thyroid labs before the morning dose, or at least 4 hours after taking the medication. Many providers do not explicitly tell patients this, and many patients do not know to ask. If you are comparing labs across time, draw conditions should be consistent.
Acute Illness and Non-Thyroidal Illness Syndrome
Serious illness, surgery, or prolonged caloric restriction can suppress Free T4 and Free T3 without any underlying thyroid disease. This pattern, sometimes called euthyroid sick syndrome or non-thyroidal illness syndrome (NTIS), is well-documented in intensive care settings. A review in Endocrine Reviews describes NTIS as an adaptive response to systemic illness rather than true thyroid dysfunction. This is why thyroid panels drawn during acute hospitalizations or significant illness are difficult to interpret and often need to be repeated after recovery.
How Often Should You Retest Free T4
For people already diagnosed with hypothyroidism and on stable levothyroxine, most guidelines recommend rechecking TSH and Free T4 at 4 to 6 weeks after any dose change, then annually once stable. The annual retest applies even when results are consistently normal — thyroid function can shift over years, particularly with autoimmune thyroid disease where antibody burden changes over time.
For people without a diagnosis who had a single borderline low Free T4, retesting in 3 to 6 months with a repeat TSH is a reasonable approach before initiating treatment. A single low-normal result in an otherwise asymptomatic person is not necessarily actionable — especially if the TSH is in range. Context, trend, and symptoms together tell a far more useful story than a single draw.
This is exactly where longitudinal tracking adds value. If your Free T4 has been 1.1 ng/dL for three years and suddenly drops to 0.85 ng/dL, that trend is worth discussing with your provider even if 0.85 ng/dL is technically within the reference range. You can upload your labs and chart your Free T4 over time to see whether your trend is stable, declining, or improving across draws — something a single report page will never show you.
Free T4 and the 'Normal but Still Symptomatic' Problem
One of the most common frustrations in thyroid medicine is presenting with fatigue, cold intolerance, brain fog, or unexplained weight gain — only to be told your labs are normal. Free T4 and TSH within the reference range does not guarantee optimal thyroid function for that individual. Reference ranges are statistical constructs derived from population averages; they describe where 95% of a sample falls, not where any one person feels best.
A related issue is that the TSH reference range itself is debated. The conventional upper limit of TSH is typically around 4.0 to 4.5 mIU/L in most US labs. Some functional medicine practitioners argue for a narrower optimal window of 1.0 to 2.5 mIU/L, citing studies suggesting that TSH values in the upper portion of the normal range are associated with more symptoms and adverse cardiovascular outcomes in certain populations. The mainstream endocrinology position has not adopted this narrower threshold — but the debate is real, and it helps explain why the research your doctor is reading may differ from what you find elsewhere. For a broader look at why TSH alone does not tell the complete story, this explainer on thyroid panel interpretation at LabHealthCharts covers related markers and tracking strategies.
What to Ask Your Doctor About Free T4
If Free T4 is on your lab report and you want a more productive conversation with your provider, specific questions yield more than vague ones. Consider: Was my blood drawn under consistent conditions (same time of day, same relationship to a levothyroxine dose)? Has my Free T4 trended in any direction across multiple draws? Should we also look at Free T3 given my symptoms? Could biotin supplementation be affecting my results? Is my TSH pattern consistent with my Free T4 result, or is there a discordance worth investigating?
Having your own copy of your results — organized by date so you can see the trend — changes the quality of that conversation. Rather than relying on memory or a single printed page from six months ago, you can show a chart. LabHealthCharts lets you track your thyroid biomarker history across every lab draw, so the trend is visible at a glance. That kind of longitudinal context is something a single lab report cannot provide.
For people also tracking metabolic health, hormones, or other biomarkers alongside thyroid function, the LabHealthCharts biomarker tracking library covers related panels that often appear on the same draw.
Key Takeaways
Free T4 measures the unbound, bioavailable fraction of thyroxine — the portion your body can actually use. Reference ranges in the US are typically 0.8 to 1.8 ng/dL (10 to 23 pmol/L internationally), but ranges vary by lab and assay method, and pregnancy requires trimester-specific thresholds.
Free T4 should always be read alongside TSH. The combination reveals whether a problem originates in the thyroid itself or in the pituitary signaling chain. Free T3 adds information about conversion efficiency but is not routinely ordered in standard screening.
Results can be affected by biotin supplementation, levothyroxine timing, acute illness, and assay variation across labs. Drawing under consistent conditions is essential for meaningful comparison across time.
A single Free T4 result rarely tells the full story. Trends across multiple draws — especially when tracked alongside TSH, Free T3, and symptoms — are what allow both patients and clinicians to see what is actually happening with thyroid function over time. LabHealthCharts shows you the trend. Your doctor interprets what it means for you.